Patrick W. Vincent
Zanzibar University(TZ)Zanzibar School of Health(TZ)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Quinazolinone synthesis and applications, Synthesis and biological activity
Most-Cited Works
- → BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis(2004)4,006 cited
- → PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib(2007)717 cited
- → Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions(2000)263 cited
- → Induced Pluripotent Stem Cell Lines Derived from Equine Fibroblasts(2011)246 cited
- → Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor(2008)221 cited
- → A Sec14p-nodulin domain phosphatidylinositol transfer protein polarizes membrane growth of Arabidopsis thaliana root hairs